HopeStage
Back to all studies
UnknownNCT02167048

Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD

Medication studyAges 6–18Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 6 years to 18 years.

Listed locations
VancouverSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJune 2014
Recruitment status
Unknown
Enrollment listed in the registry
52
Sponsor
University of British Columbia
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Canada
Age range
From 6 Years to 18 Years
Official registry ID
NCT02167048
Official title
Show the full official title

Effects of Low-dose Versus Normal-dose Psychostimulants on Executive Functions in Individuals With Attention-Deficit Hyperactivity Disorder

Recruitment & locations

Status unknown

Vancouver

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of British Columbia, a university.

Does this study involve medication?

Yes. The study involves medication, including Psychostimulants.

Who can participate?

Listed age limits: 6 years to 18 years.

Want to explore more studies?

Explore studies